|
Developing a product and getting it to market are key steps in any industry. But the need to get insurers, public or private, to reimburse the manufacturer sets the medical device industry apart. NDI Medical has the "know how" to develop reimbursement strategies and secure third-party payment for neurostimulation products.
NDI Medical's relationship with the Centers of Medicare and Medicaid Services led to the development of a coding modification strategy for motor control neuroprostheses. Led by business development manager Terri Zmina, MBA, P.T, the NDI Medical staff secured significant favorable blanket coverage of these products from such private insurance companies as Aetna and Humana. Zmina is a recognized thought leader on the subject of neurostimulation reimbursement practices and strategies and has made a number of presentations before national conferences.
As the primary insurer of the elderly and disabled, Medicare sets the standard for healthcare reimbursement in the U.S. Reimbursement strategy must be addressed early in a product's development phase to identify opportunities and risks, address potential problem areas, collect helpful data during clinical studies, and position the product for success. Three areas require careful consideration when preparing an application for reimbursement: coding, payment rate and coverage policies. A thorough analysis of the reimbursement arena early in product development will directly influence commercial success.
|
